Loading…

Efficient signal sequence of mRNA vaccines enhances the antigen expression to expand the immune protection against viral infection

The signal sequence played a crucial role in the efficacy of mRNA vaccines against virus pandemic by influencing antigen translation. However, limited research had been conducted to compare and analyze the specific mechanisms involved. In this study, a novel approach was introduced by substituting t...

Full description

Saved in:
Bibliographic Details
Published in:Journal of nanobiotechnology 2024-05, Vol.22 (1), p.295-295, Article 295
Main Authors: Zhang, Yupei, Zhai, Songhui, Huang, Hai, Qin, Shugang, Sun, Min, Chen, Yuting, Lan, Xing, Li, Guohong, Huang, Zhiying, Wang, Denggang, Luo, Yaoyao, Xiao, Wen, Li, Hao, He, Xi, Chen, Meiwan, Peng, Xingchen, Song, Xiangrong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c451t-d2049206fd9ab68c9d644deb343f1d59b950628d5b4cee110501c908771290ec3
container_end_page 295
container_issue 1
container_start_page 295
container_title Journal of nanobiotechnology
container_volume 22
creator Zhang, Yupei
Zhai, Songhui
Huang, Hai
Qin, Shugang
Sun, Min
Chen, Yuting
Lan, Xing
Li, Guohong
Huang, Zhiying
Wang, Denggang
Luo, Yaoyao
Xiao, Wen
Li, Hao
He, Xi
Chen, Meiwan
Peng, Xingchen
Song, Xiangrong
description The signal sequence played a crucial role in the efficacy of mRNA vaccines against virus pandemic by influencing antigen translation. However, limited research had been conducted to compare and analyze the specific mechanisms involved. In this study, a novel approach was introduced by substituting the signal sequence of the mRNA antigen to enhance its immune response. Computational simulations demonstrated that various signal peptides differed in their binding capacities with the signal recognition particle (SRP) 54 M subunit, which positively correlated with antigen translation efficiency. Our data revealed that the signal sequences of tPA and IL-6-modified receptor binding domain (RBD) mRNA vaccines sequentially led to higher antigen expression and elicited more robust humoral and cellular immune protection against the SARS-CoV-2 compared to the original signal sequence. By highlighting the importance of the signal sequence, this research provided a foundational and safe approach for ongoing modifications in signal sequence-antigen design, aiming to optimize the efficacy of mRNA vaccines.
doi_str_mv 10.1186/s12951-024-02488-3
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_8320420af43a40c6a212131d7d5098fe</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A795646141</galeid><doaj_id>oai_doaj_org_article_8320420af43a40c6a212131d7d5098fe</doaj_id><sourcerecordid>A795646141</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-d2049206fd9ab68c9d644deb343f1d59b950628d5b4cee110501c908771290ec3</originalsourceid><addsrcrecordid>eNptkk9v1DAQxSMEoqXwBTggS1zoIcV_E-eEVlULK1UgFThbXnucdbWxl9i7Klc-Oc6mVF0JRVGSmd88Z55eVb0l-IIQ2XxMhHaC1Jjy6ZayZs-qU8LbtmZEiOdP3k-qVyndYUwpp_xldcKkxC1h5LT6c-WcNx5CRsn3QW9Qgl87CAZQdGi4_bpAe22MD5AQhLUujYTyGpAO2fcQENxvR0jJx4BynL50sAfAD8MuANqOMYPJU1_32oeU0d6P5Rwf3Fx_Xb1wepPgzcPzrPp5ffXj8kt98-3z8nJxUxsuSK4txbyjuHG206tGms42nFtYMc4csaJbdQI3VFqx4gaAECwwMR2WbVtswmDYWbWcdW3Ud2o7-kGPv1XUXh0KceyVHrM3G1CSlcMo1o4zzbFpNCW02GVbK3AnHRStT7PWdrcawJriX9npSPS4E_xa9XGvCCGsrCGLwocHhTEWw1NWg08GNhsdIO6SYrghrRRckoK-n9Fel38rvsUiaSZcLdpONLwhfKIu_kOVy8LgTQzgfKkfDZwfDRQmw33u9S4ltfx-e8zSmTVjTGkE97gqwWoKo5rDqEoQ1SGMipWhd09Nehz5lz72F3PH2cs</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3061785481</pqid></control><display><type>article</type><title>Efficient signal sequence of mRNA vaccines enhances the antigen expression to expand the immune protection against viral infection</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central</source><creator>Zhang, Yupei ; Zhai, Songhui ; Huang, Hai ; Qin, Shugang ; Sun, Min ; Chen, Yuting ; Lan, Xing ; Li, Guohong ; Huang, Zhiying ; Wang, Denggang ; Luo, Yaoyao ; Xiao, Wen ; Li, Hao ; He, Xi ; Chen, Meiwan ; Peng, Xingchen ; Song, Xiangrong</creator><creatorcontrib>Zhang, Yupei ; Zhai, Songhui ; Huang, Hai ; Qin, Shugang ; Sun, Min ; Chen, Yuting ; Lan, Xing ; Li, Guohong ; Huang, Zhiying ; Wang, Denggang ; Luo, Yaoyao ; Xiao, Wen ; Li, Hao ; He, Xi ; Chen, Meiwan ; Peng, Xingchen ; Song, Xiangrong</creatorcontrib><description>The signal sequence played a crucial role in the efficacy of mRNA vaccines against virus pandemic by influencing antigen translation. However, limited research had been conducted to compare and analyze the specific mechanisms involved. In this study, a novel approach was introduced by substituting the signal sequence of the mRNA antigen to enhance its immune response. Computational simulations demonstrated that various signal peptides differed in their binding capacities with the signal recognition particle (SRP) 54 M subunit, which positively correlated with antigen translation efficiency. Our data revealed that the signal sequences of tPA and IL-6-modified receptor binding domain (RBD) mRNA vaccines sequentially led to higher antigen expression and elicited more robust humoral and cellular immune protection against the SARS-CoV-2 compared to the original signal sequence. By highlighting the importance of the signal sequence, this research provided a foundational and safe approach for ongoing modifications in signal sequence-antigen design, aiming to optimize the efficacy of mRNA vaccines.</description><identifier>ISSN: 1477-3155</identifier><identifier>EISSN: 1477-3155</identifier><identifier>DOI: 10.1186/s12951-024-02488-3</identifier><identifier>PMID: 38807131</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Animals ; Antibodies, Viral - immunology ; Antigens ; Antigens, Viral - chemistry ; Antigens, Viral - genetics ; Antigens, Viral - immunology ; B cells ; COVID-19 - immunology ; COVID-19 - prevention &amp; control ; COVID-19 Vaccines - immunology ; Female ; Health aspects ; Humans ; Immune response ; Immunity, Cellular ; Immunity, Humoral ; Messenger RNA ; Mice ; Mice, Inbred BALB C ; mRNA Vaccines ; Peptides ; Pharmaceutical research ; Protein Sorting Signals ; RNA sequencing ; RNA, Messenger - genetics ; SARS-CoV-2 - immunology ; Signal sequence ; Simulation methods ; SRP ; Vaccines ; Vaccines, Synthetic - immunology ; Virus</subject><ispartof>Journal of nanobiotechnology, 2024-05, Vol.22 (1), p.295-295, Article 295</ispartof><rights>2024. The Author(s).</rights><rights>COPYRIGHT 2024 BioMed Central Ltd.</rights><rights>The Author(s) 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c451t-d2049206fd9ab68c9d644deb343f1d59b950628d5b4cee110501c908771290ec3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11134928/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11134928/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,37013,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38807131$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Yupei</creatorcontrib><creatorcontrib>Zhai, Songhui</creatorcontrib><creatorcontrib>Huang, Hai</creatorcontrib><creatorcontrib>Qin, Shugang</creatorcontrib><creatorcontrib>Sun, Min</creatorcontrib><creatorcontrib>Chen, Yuting</creatorcontrib><creatorcontrib>Lan, Xing</creatorcontrib><creatorcontrib>Li, Guohong</creatorcontrib><creatorcontrib>Huang, Zhiying</creatorcontrib><creatorcontrib>Wang, Denggang</creatorcontrib><creatorcontrib>Luo, Yaoyao</creatorcontrib><creatorcontrib>Xiao, Wen</creatorcontrib><creatorcontrib>Li, Hao</creatorcontrib><creatorcontrib>He, Xi</creatorcontrib><creatorcontrib>Chen, Meiwan</creatorcontrib><creatorcontrib>Peng, Xingchen</creatorcontrib><creatorcontrib>Song, Xiangrong</creatorcontrib><title>Efficient signal sequence of mRNA vaccines enhances the antigen expression to expand the immune protection against viral infection</title><title>Journal of nanobiotechnology</title><addtitle>J Nanobiotechnology</addtitle><description>The signal sequence played a crucial role in the efficacy of mRNA vaccines against virus pandemic by influencing antigen translation. However, limited research had been conducted to compare and analyze the specific mechanisms involved. In this study, a novel approach was introduced by substituting the signal sequence of the mRNA antigen to enhance its immune response. Computational simulations demonstrated that various signal peptides differed in their binding capacities with the signal recognition particle (SRP) 54 M subunit, which positively correlated with antigen translation efficiency. Our data revealed that the signal sequences of tPA and IL-6-modified receptor binding domain (RBD) mRNA vaccines sequentially led to higher antigen expression and elicited more robust humoral and cellular immune protection against the SARS-CoV-2 compared to the original signal sequence. By highlighting the importance of the signal sequence, this research provided a foundational and safe approach for ongoing modifications in signal sequence-antigen design, aiming to optimize the efficacy of mRNA vaccines.</description><subject>Animals</subject><subject>Antibodies, Viral - immunology</subject><subject>Antigens</subject><subject>Antigens, Viral - chemistry</subject><subject>Antigens, Viral - genetics</subject><subject>Antigens, Viral - immunology</subject><subject>B cells</subject><subject>COVID-19 - immunology</subject><subject>COVID-19 - prevention &amp; control</subject><subject>COVID-19 Vaccines - immunology</subject><subject>Female</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Immune response</subject><subject>Immunity, Cellular</subject><subject>Immunity, Humoral</subject><subject>Messenger RNA</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>mRNA Vaccines</subject><subject>Peptides</subject><subject>Pharmaceutical research</subject><subject>Protein Sorting Signals</subject><subject>RNA sequencing</subject><subject>RNA, Messenger - genetics</subject><subject>SARS-CoV-2 - immunology</subject><subject>Signal sequence</subject><subject>Simulation methods</subject><subject>SRP</subject><subject>Vaccines</subject><subject>Vaccines, Synthetic - immunology</subject><subject>Virus</subject><issn>1477-3155</issn><issn>1477-3155</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkk9v1DAQxSMEoqXwBTggS1zoIcV_E-eEVlULK1UgFThbXnucdbWxl9i7Klc-Oc6mVF0JRVGSmd88Z55eVb0l-IIQ2XxMhHaC1Jjy6ZayZs-qU8LbtmZEiOdP3k-qVyndYUwpp_xldcKkxC1h5LT6c-WcNx5CRsn3QW9Qgl87CAZQdGi4_bpAe22MD5AQhLUujYTyGpAO2fcQENxvR0jJx4BynL50sAfAD8MuANqOMYPJU1_32oeU0d6P5Rwf3Fx_Xb1wepPgzcPzrPp5ffXj8kt98-3z8nJxUxsuSK4txbyjuHG206tGms42nFtYMc4csaJbdQI3VFqx4gaAECwwMR2WbVtswmDYWbWcdW3Ud2o7-kGPv1XUXh0KceyVHrM3G1CSlcMo1o4zzbFpNCW02GVbK3AnHRStT7PWdrcawJriX9npSPS4E_xa9XGvCCGsrCGLwocHhTEWw1NWg08GNhsdIO6SYrghrRRckoK-n9Fel38rvsUiaSZcLdpONLwhfKIu_kOVy8LgTQzgfKkfDZwfDRQmw33u9S4ltfx-e8zSmTVjTGkE97gqwWoKo5rDqEoQ1SGMipWhd09Nehz5lz72F3PH2cs</recordid><startdate>20240528</startdate><enddate>20240528</enddate><creator>Zhang, Yupei</creator><creator>Zhai, Songhui</creator><creator>Huang, Hai</creator><creator>Qin, Shugang</creator><creator>Sun, Min</creator><creator>Chen, Yuting</creator><creator>Lan, Xing</creator><creator>Li, Guohong</creator><creator>Huang, Zhiying</creator><creator>Wang, Denggang</creator><creator>Luo, Yaoyao</creator><creator>Xiao, Wen</creator><creator>Li, Hao</creator><creator>He, Xi</creator><creator>Chen, Meiwan</creator><creator>Peng, Xingchen</creator><creator>Song, Xiangrong</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20240528</creationdate><title>Efficient signal sequence of mRNA vaccines enhances the antigen expression to expand the immune protection against viral infection</title><author>Zhang, Yupei ; Zhai, Songhui ; Huang, Hai ; Qin, Shugang ; Sun, Min ; Chen, Yuting ; Lan, Xing ; Li, Guohong ; Huang, Zhiying ; Wang, Denggang ; Luo, Yaoyao ; Xiao, Wen ; Li, Hao ; He, Xi ; Chen, Meiwan ; Peng, Xingchen ; Song, Xiangrong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-d2049206fd9ab68c9d644deb343f1d59b950628d5b4cee110501c908771290ec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Antibodies, Viral - immunology</topic><topic>Antigens</topic><topic>Antigens, Viral - chemistry</topic><topic>Antigens, Viral - genetics</topic><topic>Antigens, Viral - immunology</topic><topic>B cells</topic><topic>COVID-19 - immunology</topic><topic>COVID-19 - prevention &amp; control</topic><topic>COVID-19 Vaccines - immunology</topic><topic>Female</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Immune response</topic><topic>Immunity, Cellular</topic><topic>Immunity, Humoral</topic><topic>Messenger RNA</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>mRNA Vaccines</topic><topic>Peptides</topic><topic>Pharmaceutical research</topic><topic>Protein Sorting Signals</topic><topic>RNA sequencing</topic><topic>RNA, Messenger - genetics</topic><topic>SARS-CoV-2 - immunology</topic><topic>Signal sequence</topic><topic>Simulation methods</topic><topic>SRP</topic><topic>Vaccines</topic><topic>Vaccines, Synthetic - immunology</topic><topic>Virus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Yupei</creatorcontrib><creatorcontrib>Zhai, Songhui</creatorcontrib><creatorcontrib>Huang, Hai</creatorcontrib><creatorcontrib>Qin, Shugang</creatorcontrib><creatorcontrib>Sun, Min</creatorcontrib><creatorcontrib>Chen, Yuting</creatorcontrib><creatorcontrib>Lan, Xing</creatorcontrib><creatorcontrib>Li, Guohong</creatorcontrib><creatorcontrib>Huang, Zhiying</creatorcontrib><creatorcontrib>Wang, Denggang</creatorcontrib><creatorcontrib>Luo, Yaoyao</creatorcontrib><creatorcontrib>Xiao, Wen</creatorcontrib><creatorcontrib>Li, Hao</creatorcontrib><creatorcontrib>He, Xi</creatorcontrib><creatorcontrib>Chen, Meiwan</creatorcontrib><creatorcontrib>Peng, Xingchen</creatorcontrib><creatorcontrib>Song, Xiangrong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of nanobiotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Yupei</au><au>Zhai, Songhui</au><au>Huang, Hai</au><au>Qin, Shugang</au><au>Sun, Min</au><au>Chen, Yuting</au><au>Lan, Xing</au><au>Li, Guohong</au><au>Huang, Zhiying</au><au>Wang, Denggang</au><au>Luo, Yaoyao</au><au>Xiao, Wen</au><au>Li, Hao</au><au>He, Xi</au><au>Chen, Meiwan</au><au>Peng, Xingchen</au><au>Song, Xiangrong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficient signal sequence of mRNA vaccines enhances the antigen expression to expand the immune protection against viral infection</atitle><jtitle>Journal of nanobiotechnology</jtitle><addtitle>J Nanobiotechnology</addtitle><date>2024-05-28</date><risdate>2024</risdate><volume>22</volume><issue>1</issue><spage>295</spage><epage>295</epage><pages>295-295</pages><artnum>295</artnum><issn>1477-3155</issn><eissn>1477-3155</eissn><abstract>The signal sequence played a crucial role in the efficacy of mRNA vaccines against virus pandemic by influencing antigen translation. However, limited research had been conducted to compare and analyze the specific mechanisms involved. In this study, a novel approach was introduced by substituting the signal sequence of the mRNA antigen to enhance its immune response. Computational simulations demonstrated that various signal peptides differed in their binding capacities with the signal recognition particle (SRP) 54 M subunit, which positively correlated with antigen translation efficiency. Our data revealed that the signal sequences of tPA and IL-6-modified receptor binding domain (RBD) mRNA vaccines sequentially led to higher antigen expression and elicited more robust humoral and cellular immune protection against the SARS-CoV-2 compared to the original signal sequence. By highlighting the importance of the signal sequence, this research provided a foundational and safe approach for ongoing modifications in signal sequence-antigen design, aiming to optimize the efficacy of mRNA vaccines.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>38807131</pmid><doi>10.1186/s12951-024-02488-3</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1477-3155
ispartof Journal of nanobiotechnology, 2024-05, Vol.22 (1), p.295-295, Article 295
issn 1477-3155
1477-3155
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_8320420af43a40c6a212131d7d5098fe
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central
subjects Animals
Antibodies, Viral - immunology
Antigens
Antigens, Viral - chemistry
Antigens, Viral - genetics
Antigens, Viral - immunology
B cells
COVID-19 - immunology
COVID-19 - prevention & control
COVID-19 Vaccines - immunology
Female
Health aspects
Humans
Immune response
Immunity, Cellular
Immunity, Humoral
Messenger RNA
Mice
Mice, Inbred BALB C
mRNA Vaccines
Peptides
Pharmaceutical research
Protein Sorting Signals
RNA sequencing
RNA, Messenger - genetics
SARS-CoV-2 - immunology
Signal sequence
Simulation methods
SRP
Vaccines
Vaccines, Synthetic - immunology
Virus
title Efficient signal sequence of mRNA vaccines enhances the antigen expression to expand the immune protection against viral infection
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T12%3A32%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficient%20signal%20sequence%20of%20mRNA%20vaccines%20enhances%20the%20antigen%20expression%20to%20expand%20the%20immune%20protection%20against%20viral%20infection&rft.jtitle=Journal%20of%20nanobiotechnology&rft.au=Zhang,%20Yupei&rft.date=2024-05-28&rft.volume=22&rft.issue=1&rft.spage=295&rft.epage=295&rft.pages=295-295&rft.artnum=295&rft.issn=1477-3155&rft.eissn=1477-3155&rft_id=info:doi/10.1186/s12951-024-02488-3&rft_dat=%3Cgale_doaj_%3EA795646141%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c451t-d2049206fd9ab68c9d644deb343f1d59b950628d5b4cee110501c908771290ec3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3061785481&rft_id=info:pmid/38807131&rft_galeid=A795646141&rfr_iscdi=true